Advarra, the market leader in regulatory reviews and a leading provider of clinical research technology, today announced the ...
Recommending to revise the inclusion criteria so that subjects on triple therapy only shall be included in the study, the ...
A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the ...
Generative artificial intelligence (AI) has absolutely exploded onto the scene. It's become a top strategic priority in the ...
Behavioral variability is quietly sabotaging clinical trials—but it doesn't have to. Here's how predictive behavioral modeling can improve trial design, reduce dropout, and deliver more inclusive, ...
MELVILLE, N.Y., April 16, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based ...
PhaseV, a leader in AI/ML for clinical development, today announced a strategic partnership with Bioforum, a leading Contract ...
According to ESC, these recommendations respond directly to a request from the European Commission to provide expert advice ...
As an essential component of the drug development process, human clinical trials assist in determining whether a given drug will serve its intended purpose, but patent applicants should consider ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback